Advanced Endometrial Cancer: Treatment Optimization : Episode 1

Symptoms and Diagnosis of Endometrial Cancer

November 22, 2022

By Courtney R. Arn, APRN-CNP
Kimberly Halla, NP

Commentary

Video

Kimberly A. Spickes, CNP, gives an overview of the typical symptoms women with endometrial cancer present with, discusses how these symptoms are similar and different from those seen with other gynecologic malignancies, and reviews risk factors for endometrial cancer.

Now Viewing

EP: 1.Symptoms and Diagnosis of Endometrial Cancer

EP: 2.Initial Consultation of Patients With Advanced Endometrial Cancer

EP: 3.Conversations with Patients With Advanced Endometrial Cancer Before and After Diagnosis

EP: 4.Resources for Patients With Endometrial Cancer

EP: 5.Patient Profile Presentation: A 76-Year-Old Woman With Advanced Endometrial Cancer

EP: 6.Fertility and Other Treatment Considerations for Patients With Advanced Endometrial Cancer

EP: 7.Currently Available Treatment Modalities in Endometrial Cancer

EP: 8.First-Line Treatments for Patients With Advanced Endometrial Cancer Who Are Unfit for Surgery

EP: 9.Common Adverse Events Seen With Chemotherapy for Advanced Endometrial Cancer

EP: 10.Efficacy of Chemotherapy in Patients with Advanced Endometrial Cancer

EP: 11.Treatment Options for Patients with Recurrent Endometrial Cancer

EP: 12.Educating Patients With Endometrial Cancer on Treatment-Related Adverse Events

EP: 13.Monitoring Patients on Therapy for Recurrent Endometrial Cancer

EP: 14.Adverse Events Seen With Combination Lenvatinib and Pembrolizumab for Recurrent Endometrial Cancer

EP: 15.Proactive Adverse Effect Management for Patients on Therapy for Endometrial Cancer

EP: 16.Discussing Dose Reductions and Interruptions with Patients on Therapy for Endometrial Cancer

EP: 17.Greatest Unmet Needs for Patients with Endometrial Cancer

EP: 18.Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer

Related Content

Sacituzumab Tirumotecan Shows Promise in Pretreated Gynecologic Cancer

Ashley Chan

November 18th 2024

Article

Sacituzumab tirumotecan had antitumor activity in pretreated advanced endometrial and ovarian cancer, data showed.

Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

Lindsay Fischer

June 15th 2023

Podcast

Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.

clinician in white coat holding a board that says "cervical cancer"

Adding Cancer Vaccine to Avelumab Doesn’t Boost PFS in Gynecologic Cancer

Russ Conroy

October 16th 2024

Article

The addition of T4001, an investigation cancer vaccine, to avelumab did not improve progression-free survival vs avelumab alone in cervical and anogenital tumors.

A Look Back at 2022 FDA Approvals in Oncology

Oncology Nursing News

January 2nd 2023

Podcast

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

WHO Updates Cervical Cancer Prevention Guidelines

Chris Ryan

October 8th 2024

Article

The World Health Organization updated their guidelines to include CINtec PLUS Cytology for gynecologic cancer prevention.

Dato-DXd Seems Safe, Efficacious in Advanced Gynecologic Cancers

Jason M. Broderick

September 18th 2024

Article

Datopotamab deruxtecan(Dato-DXd) demonstrated antitumor activity in patients with advanced/metastatic ovarian or endometrial cancer who had prior chemotherapy treatment.

Related Content

Sacituzumab Tirumotecan Shows Promise in Pretreated Gynecologic Cancer

Ashley Chan

November 18th 2024

Article

Sacituzumab tirumotecan had antitumor activity in pretreated advanced endometrial and ovarian cancer, data showed.

Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

Lindsay Fischer

June 15th 2023

Podcast

Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.

Adding Cancer Vaccine to Avelumab Doesn’t Boost PFS in Gynecologic Cancer

Russ Conroy

October 16th 2024

Article

The addition of T4001, an investigation cancer vaccine, to avelumab did not improve progression-free survival vs avelumab alone in cervical and anogenital tumors.

A Look Back at 2022 FDA Approvals in Oncology

Oncology Nursing News

January 2nd 2023

Podcast

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

WHO Updates Cervical Cancer Prevention Guidelines

Chris Ryan

October 8th 2024

Article

The World Health Organization updated their guidelines to include CINtec PLUS Cytology for gynecologic cancer prevention.

Dato-DXd Seems Safe, Efficacious in Advanced Gynecologic Cancers

Jason M. Broderick

September 18th 2024

Article

Datopotamab deruxtecan(Dato-DXd) demonstrated antitumor activity in patients with advanced/metastatic ovarian or endometrial cancer who had prior chemotherapy treatment.